Greenphire Executives to Participate INC Research and CISCRP’s “Inspiring Hope” Ideathon

King of Prussia, PA – September 15, 2016 – Greenphire, the global leader in clinical payment solutions, today announced that it will participate in INC Research and CISCRP’s “Inspiring Hope” Ideathon, a competition taking place in Boston on September 27 – 28.

According to CISCRP, less than 5 percent of the population ever participate in a clinical trial. The “Inspiring Hope” event is designed to promote greater awareness of the importance of clinical trial participation in advancing public health. Greenphire’s CEO Jim Murphy and Vice President of Business Development Rick Ward will collaborate and provide mentorship to the finalists in the contest that will ultimately present their ideas to an expert judging panel. The winning idea will receive the 2016 “Inspiring Hope” Award, including a $10,000 cash prize.

“A clinical trial’s ability to bring new treatments to market resides in the ability to successfully recruit and retain clinical trial participants,” said Jim Murphy, CEO of Greenphire. “We are thrilled to have the opportunity to support this community of forward thinking problem solvers and look forward to hearing the new and innovative ideas that will inspire clinical research participation.”

Greenphire’s solutions provide a better way to pay clinical trial participants and research sites, resulting in an improved trial experience for all involved. The ClinCard solution is leveraged by sponsors, CROs and research sites around the world to provide patients with instant, convenient access to funds via a reloadable debit card, eliminating any financial hurdles that may impact ongoing clinical trial participation and engagement. Sponsors and CROs leverage Greenphire’s eClinicalGPS solution to automate, streamline and accelerate research site payments, supporting the research site’s sustainability and success.

To learn more about the “Inspiring Hope” Ideathon, please visit www.inspiring-hope-ideathon.com.

About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

About CISCRP

The Center for Information and Study on Clinical Research Participation (CISCRP) is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research and the role each party plays in the process. CISCRP provides free education and outreach to the general public and patient communities. Visit www.CISCRP.org for more information or to support CISCRP.

About INC Research

INC Research (Nasdaq:INCR) is a leading global contract research organization (“CRO”) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey.  INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.